Supplementary Table S7 from CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy

<p>Supplementary Table S7. DEGs for 1 month Comparison of CD49d+ and CD49d-</p>

Bewaard in:
Bibliografische gegevens
Hoofdauteur: Anfal Alsadhan (15907475) (author)
Andere auteurs: Jonathan Chen (15907478) (author), Erika M. Gaglione (15032498) (author), Chingiz Underbayev (15907481) (author), Pamela L. Tuma (15907484) (author), Xin Tian (15907487) (author), Lita A. Freeman (15907490) (author), Sivasubramanian Baskar (15907493) (author), Pia Nierman (15907496) (author), Susan Soto (15907499) (author), Andy Itsara (15907502) (author), Inhye E. Ahn (15032501) (author), Clare Sun (14953020) (author), Elena Bibikova (15907505) (author), Tanja Nicole Hartmann (15907508) (author), Maissa Mhibik (15907511) (author), Adrian Wiestner (15907514) (author)
Gepubliceerd in: 2025
Onderwerpen:
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
_version_ 1849927632373678080
author Anfal Alsadhan (15907475)
author2 Jonathan Chen (15907478)
Erika M. Gaglione (15032498)
Chingiz Underbayev (15907481)
Pamela L. Tuma (15907484)
Xin Tian (15907487)
Lita A. Freeman (15907490)
Sivasubramanian Baskar (15907493)
Pia Nierman (15907496)
Susan Soto (15907499)
Andy Itsara (15907502)
Inhye E. Ahn (15032501)
Clare Sun (14953020)
Elena Bibikova (15907505)
Tanja Nicole Hartmann (15907508)
Maissa Mhibik (15907511)
Adrian Wiestner (15907514)
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author_facet Anfal Alsadhan (15907475)
Jonathan Chen (15907478)
Erika M. Gaglione (15032498)
Chingiz Underbayev (15907481)
Pamela L. Tuma (15907484)
Xin Tian (15907487)
Lita A. Freeman (15907490)
Sivasubramanian Baskar (15907493)
Pia Nierman (15907496)
Susan Soto (15907499)
Andy Itsara (15907502)
Inhye E. Ahn (15032501)
Clare Sun (14953020)
Elena Bibikova (15907505)
Tanja Nicole Hartmann (15907508)
Maissa Mhibik (15907511)
Adrian Wiestner (15907514)
author_role author
dc.creator.none.fl_str_mv Anfal Alsadhan (15907475)
Jonathan Chen (15907478)
Erika M. Gaglione (15032498)
Chingiz Underbayev (15907481)
Pamela L. Tuma (15907484)
Xin Tian (15907487)
Lita A. Freeman (15907490)
Sivasubramanian Baskar (15907493)
Pia Nierman (15907496)
Susan Soto (15907499)
Andy Itsara (15907502)
Inhye E. Ahn (15032501)
Clare Sun (14953020)
Elena Bibikova (15907505)
Tanja Nicole Hartmann (15907508)
Maissa Mhibik (15907511)
Adrian Wiestner (15907514)
dc.date.none.fl_str_mv 2025-11-25T13:26:58Z
dc.identifier.none.fl_str_mv 10.1158/1078-0432.30709084
dc.relation.none.fl_str_mv https://figshare.com/articles/dataset/Supplementary_Table_S7_from_CD49d_Expression_Identifies_a_Biologically_Distinct_Subtype_of_Chronic_Lymphocytic_Leukemia_with_Inferior_Progression-Free_Survival_on_BTK_Inhibitor_Therapy/30709084
dc.rights.none.fl_str_mv CC BY
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Cancer
Molecular and Cellular Biology
Therapeutic Research and Development
Immuno-oncology
Cell Signaling
Cell adhesion
Protein tyrosine kinases
Drug Resistance
Hematological Cancers
Leukemias
Lymphomas
Immunology
Immunomodulation
dc.title.none.fl_str_mv Supplementary Table S7 from CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy
dc.type.none.fl_str_mv Dataset
info:eu-repo/semantics/publishedVersion
dataset
description <p>Supplementary Table S7. DEGs for 1 month Comparison of CD49d+ and CD49d-</p>
eu_rights_str_mv openAccess
id Manara_15e920b3c6ac003153d0b469b9dd4814
identifier_str_mv 10.1158/1078-0432.30709084
network_acronym_str Manara
network_name_str ManaraRepo
oai_identifier_str oai:figshare.com:article/30709084
publishDate 2025
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY
spelling Supplementary Table S7 from CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor TherapyAnfal Alsadhan (15907475)Jonathan Chen (15907478)Erika M. Gaglione (15032498)Chingiz Underbayev (15907481)Pamela L. Tuma (15907484)Xin Tian (15907487)Lita A. Freeman (15907490)Sivasubramanian Baskar (15907493)Pia Nierman (15907496)Susan Soto (15907499)Andy Itsara (15907502)Inhye E. Ahn (15032501)Clare Sun (14953020)Elena Bibikova (15907505)Tanja Nicole Hartmann (15907508)Maissa Mhibik (15907511)Adrian Wiestner (15907514)CancerMolecular and Cellular BiologyTherapeutic Research and DevelopmentImmuno-oncologyCell SignalingCell adhesionProtein tyrosine kinasesDrug ResistanceHematological CancersLeukemiasLymphomasImmunologyImmunomodulation<p>Supplementary Table S7. DEGs for 1 month Comparison of CD49d+ and CD49d-</p>2025-11-25T13:26:58ZDatasetinfo:eu-repo/semantics/publishedVersiondataset10.1158/1078-0432.30709084https://figshare.com/articles/dataset/Supplementary_Table_S7_from_CD49d_Expression_Identifies_a_Biologically_Distinct_Subtype_of_Chronic_Lymphocytic_Leukemia_with_Inferior_Progression-Free_Survival_on_BTK_Inhibitor_Therapy/30709084CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/307090842025-11-25T13:26:58Z
spellingShingle Supplementary Table S7 from CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy
Anfal Alsadhan (15907475)
Cancer
Molecular and Cellular Biology
Therapeutic Research and Development
Immuno-oncology
Cell Signaling
Cell adhesion
Protein tyrosine kinases
Drug Resistance
Hematological Cancers
Leukemias
Lymphomas
Immunology
Immunomodulation
status_str publishedVersion
title Supplementary Table S7 from CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy
title_full Supplementary Table S7 from CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy
title_fullStr Supplementary Table S7 from CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy
title_full_unstemmed Supplementary Table S7 from CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy
title_short Supplementary Table S7 from CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy
title_sort Supplementary Table S7 from CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy
topic Cancer
Molecular and Cellular Biology
Therapeutic Research and Development
Immuno-oncology
Cell Signaling
Cell adhesion
Protein tyrosine kinases
Drug Resistance
Hematological Cancers
Leukemias
Lymphomas
Immunology
Immunomodulation